Carl Icahn Just Bought Another $500 Million Worth of Apple
Icahn now uses Twitter to communicate his messages rapidly, and the latest tweet shows that he just bought $500 million more in Apple stock. He even joked that his buying is the same as…
All Work
Jon C. Ogg
J.C. Penney Poison Pill May Make It Immune to Activists and Acquirers
J. C. Penney remains challenged. A new release from the company signals one of two outcomes. First is that it could be taken over against its will. The second is that the company thinks…
Consumer Confidence Starts 2014 With Handy Gains
ThinkstockThe Conference Board has released its Consumer Confidence Index for January. The good news for the economy is that it is far better than the horrific durable goods report from the Commerce Department earlier…
Key Changes in Financial Stock Short Interest
The old saying is that financial stocks are indicators of broad market strength or weakness, so that makes it imperative to watch what short sellers are doing. 24/7 Wall St. has tracked short interest…
Oppenheimer Grows Leery of Companies That Depend on Apple
Oppenheimer is one of the Wall Street firms that feels Apple is losing its luster. With intense smartphone and tablet competition, the firm feels that the current product cycle for the company is exhausted.
Durable Goods So Weak They Changed the Name to Dismal Goods
ThinkstockTuesday’s top economic report was the durable goods report for December, and unfortunately it is a very ugly number. The headline durable goods report from the Commerce Department was negative and down by 4.3%…
Top Analyst Upgrades and Downgrades: Apple, BioCryst, Dow Chemical, Sanmina, Sally Beauty and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, January 28, 2014. They include Apple, Dow Chemical and Sally Beauty.
Pfizer Delivers on Earnings, Sets 2014 Guidance
Pfizer has managed to handily beat consensus fourth-quarter earnings expectations, at least on the surface. It also offered guidance for 2014 in line with consensus estimates.
As Twitter Reality Sets In, Social Media Gets Crushed
courtesy of TwitterThe valuation concern is back in social media, and perhaps fears of a market correction make the reality check even that much more important. Twitter, Inc. (NYSE: TWTR) saw on Monday that…
Apple Earnings Lack iPhone Power-Punch
courtesy of Apple Inc.Apple Inc. (NASDAQ: AAPL) is one of the most anticipated earnings report of this earnings season. After all, its market cap of close to $500 million is the largest there is.…
Micron Wipes Out Debt and Stops Share Dilution -Model Financial Math?
thinkstockMicron Technology, Inc. (NASDAQ: MU) has already had a handy turnaround, moving from being a DRAM-dependent commodity business into DRAM and flash. It has also participated in the consolidation phase of the sector. Now…
When a Top Revenue Officer Replaces Founding CEO – A Win!
ThinkstockSometimes it turns out that businesses are just better off without their founder, or founders, running the show. This seems to be the case for Millennial Media Inc. (NYSE: MM) after announcing that company…
YRC Pact Likely Bad for Competitors
YRC Worldwide is enjoying the benefits of a its union deal, although this gain likely is coming at the expenses of its peers and competitors. The company can now focus on restructuring and refinancing…
Analyst Team Sees Strong Biotech Buyout Market in 2014
Analysts at at Merrill Lynch see 2014 as a promising year for biotech mergers and acquisitions. A new research report shows which companies they believe will make acquisitions or which will be interested in…
Analysts Cap AMC as Quiet Period Ends
The so-called underwriter quiet period for AMC Entertainment Holdings has come to an end, so now the analysts in the underwriting syndicate firms can issue coverage on the company. Shares were down in the…
Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside
Once again, the analysts at Piper Jaffray are conducting extensive management meetings with the companies they cover. Here are the seven top biopharma stocks to buy now, according to Piper Jaffray.
Top Analyst Upgrades and Downgrades: Cisco, Lululemon, Nokia, Peabody, Xerox and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, January 27, 2014. They include Cisco Systems, Lululemon Athletica, Nokia, Peabody Energy and Xerox.
Are Activist Investors Starting to Overreach and Hurt Companies?
24/7 Wall St. takes a look at some of the stocks that are being or have been pushed and cajoled by activist investors. In many cases, the activist investors helped the smaller investors by…
Postage Hike Savings Die Saturday, Stamps.com, UPS and FedEx Mirror
courtesy of USPSIf prices of goods or services are rising or falling, it often means that someone is winning and someone is losing as a result. As a general service reminder, and hopefully a…
Five Big Stocks That Escaped the Market Carnage Sell-Off
The stock market was pounded on Friday, making for a very bad week and a rough start for January. Still, not all is lost. A few stocks managed to avoid the carnage. Despite a…